You just read:

NeuClone to Initiate Phase I Clinical Trial of Stelara (Ustekinumab) Biosimilar, the Second Biosimilar from the 10-product Portfolio with Serum Institute

News provided by

NeuClone Pharmaceuticals Ltd.

May 15, 2019, 08:13 ET